BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25260564)

  • 1. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
    Takeshita J; Wang S; Shin DB; Callis Duffin K; Krueger GG; Kalb RE; Weisman JD; Sperber BR; Stierstorfer MB; Brod BA; Schleicher SM; Robertson AD; Linn KA; Shinohara RT; Troxel AB; Van Voorhees AS; Gelfand JM
    J Am Acad Dermatol; 2014 Dec; 71(6):1167-75. PubMed ID: 25260564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.
    Duffin KC; Yeung H; Takeshita J; Krueger GG; Robertson AD; Troxel AB; Shin DB; Van Voorhees AS; Gelfand JM
    Br J Dermatol; 2014 Mar; 170(3):672-680. PubMed ID: 24266717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Singh S; Kalb RE; de Jong EMGJ; Shear NH; Lebwohl M; Langholff W; Hopkins L; Srivastava B; Armstrong AW
    Am J Clin Dermatol; 2018 Dec; 19(6):879-886. PubMed ID: 30267377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Psoriasis Therapies.
    James J; Otto T; Gao J; Porter ML
    Dermatol Clin; 2024 Jul; 42(3):357-363. PubMed ID: 38796267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
    Chat VS; Ellebrecht CT; Kingston P; Gondo G; Bell S; Cordoro KM; Desai SR; Duffin KC; Feldman SR; Garg A; Gelfand JM; Gladman D; Green LJ; Gudjonsson J; Han G; Hawkes JE; Kircik L; Koo J; Langley R; Lebwohl M; Michael Lewitt G; Liao W; Martin G; Orbai AM; Reddy SM; Richardson V; Ritchlin CT; Schwartzman S; Siegel EL; Van Voorhees AS; Wallace EB; Weinberg JM; Winthrop KL; Yamauchi P; Armstrong AW
    J Am Acad Dermatol; 2024 Jun; 90(6):1170-1181. PubMed ID: 38331098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
    Dickel H; Bruckner T; Altmeyer P
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of renal function in patients with psoriasis using immunobiologicals.
    Melgaço SS; Silva GB; Dantas AM; Vasconcelos AM; Siqueira VR; Vieira AP; Daher Ede F
    An Bras Dermatol; 2013; 88(4):667-9. PubMed ID: 24068151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.
    Armstrong AW; Aldredge L; Yamauchi PS
    J Cutan Med Surg; 2016 May; 20(3):196-206. PubMed ID: 26712930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial.
    Prinsen CA; Spuls PI; Sprangers MA; de Rie MA; Legierse CM; de Korte J
    Trials; 2012 Dec; 13():236. PubMed ID: 23216943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.
    Li J; Wang S; Li XD; Han Y
    J Int Med Res; 2024 Apr; 52(4):3000605241247702. PubMed ID: 38661102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.
    van Huizen A; Bank P; van der Kraaij G; Musters A; Busard C; Menting S; Rispens T; de Vries A; van Doorn M; Prens E; Lambert J; van den Reek J; de Jong E; Mathôt R; Spuls P
    J Invest Dermatol; 2024 Apr; 144(4):794-801.e6. PubMed ID: 37992959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.
    Schmitt J; Wozel G
    Biologics; 2009; 3():303-18. PubMed ID: 19707417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis.
    Greenzaid J; Feldman S
    Clin Pharmacokinet; 2024 Feb; 63(2):137-153. PubMed ID: 38280146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients.
    Eichinger JM; Shan DM; Greenzaid JD; Anakwenze L; Feldman SR
    Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):249-262. PubMed ID: 38529623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau.
    Chularojanamontri L; Silpa-Archa N; Pattamadilok B; Julanon N; Chuamanochan M; Pongcharoen P; Lertphanichkul C; Asawanonda P
    Exp Dermatol; 2024 Mar; 33(3):e15055. PubMed ID: 38519437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers in the etiology of psoriasis: Targeted treatment options.
    de Felice C; Marulli GC; Ardigò M; Berardesca E
    Biologics; 2007 Mar; 1(1):11-8. PubMed ID: 19707344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil.
    Silveira MS; de Camargo IA; Osorio-de-Castro CG; Barberato-Filho S; Del Fiol Fde S; Guyatt G; de Camargo MC; Lopes LC
    BMJ Open; 2014 Mar; 4(3):e004179. PubMed ID: 24598304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrodermic psoriasis: pathophysiology and current treatment perspectives.
    Singh RK; Lee KM; Ucmak D; Brodsky M; Atanelov Z; Farahnik B; Abrouk M; Nakamura M; Zhu TH; Liao W
    Psoriasis (Auckl); 2016; 6():93-104. PubMed ID: 28856115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guide to prescribing systemic treatments for psoriasis during pregnancy, breastfeeding and in those trying to conceive: what does the current evidence suggest?
    Hutchison E; Eraifej N; Moss J; Rolls S; Wainman H
    Clin Exp Dermatol; 2024 May; ():. PubMed ID: 38769610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations of systemic methotrexate toxicity.
    Jain S; Pyle HJ; Evans JC; Gao W; Mauskar MM
    JAAD Int; 2024 Jun; 15():179-181. PubMed ID: 38651037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.